There is one clinical trial.
This non-interventional, observational study retrospectively (and in parts prospectively) investigates, if a Covid-19 associated Nephritis, diagnosed by Urine-dipstick and further Urine-analyses on addmission, can help to predict later complications, adverse outcomes and later need for ICU-capacity in Covid-19 patients as well as can guide preventive strategies.
Description: Time (in days) from hospital admission to transferral to ICU (ICU level high) OR time (in days) from Hospital Admission to DeathMeasure: Time to Disease-Aggravation Time: during first 10 days after admission to hospital
Description: Number of Complications are defined as Need of transferral to "ICU low" (ICU level 1)* Need of transferral to "ICU high" (ICU level 3)* Need of mechanical ventilation* OR Need for renal replacement therapy* OR Need of extracorporeal membrane oxygenation* OR Death * in the first 10 days after admission to hospitalMeasure: Complications Time: during first 10 days after admission to hospital
Description: Time on "ICU low" (in days), Time on "ICU high" (in days), Time on invasive mechanical ventilation (in days) Time on extracorporeal membrane oxygenation (in days) Time on renal replacement therapy (in days)Measure: Resources Time: during hospital stay, up to 2 months
Description: lowest serum-albumin lowest antithrombin IIIMeasure: Blood-test Time: during hospital stay, up to 2 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports